Cellnex


18/11/25 -"Following the Q3 release, we have made minor adjustments to our figures. While EBITDA remains mostly unchanged, there is a slight increase in D&A, resulting in a decrease in EPS. Although this ..."

Pages
55
Language
English
Published on
18/11/25
You may also be interested by these reports :
27/02/26
The key announcement expected to impact negatively the stock price today is the group’s decision to reduce its dividend. The group plans to halve it ...

26/02/26
A Krach in Q4… after strong and steady increase for 3 years Since the end of 2022 and the market recovery, Telefonica (BUY ; Spain)’s stock price had ...

26/02/26
DT’s European annual results met our expectations. Deutsche Telekom’s stock rose by 11% after TMUS’s annual release. It is anticipated to continue ...

19/02/26
Orange reported strong Q4 results, meeting expectations. Organic cash flow which was projected at a minimum of €3.6bn achieved €3.65bn, an 8.3% ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO